MCHT yields 2.64% · ABBV yields 3.06%● Live data
📍 ABBV pulled ahead of the other in Year 1
Combined, MCHT + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MCHT + ABBV for your $10,000?
Mauch Chunk Trust Financial Corp. operates as the bank holding company for Mauch Chunk Trust Company that provides various banking products and services primarily in Carbon County, Pennsylvania. The company accepts various deposit products, including checking, savings, and money market accounts; certificates of deposit; and individual retirement accounts. It also offers residential mortgage, home equity, personal, small business, commercial real estate, and commercial line of credit and term loans; home equity line of credit; and commercial letters of credit, as well as various leasing and real estate investing products. In addition, the company provides investment services, such as stocks, bonds, mutual funds, exchange traded funds, annuities, managed accounts, and life insurance, as well as securities and advisory services; credit and debit cards, direct and remote deposits, switch kits, check reorders, merchant, and other services; online, mobile, and telephone banking; cash management; trust; and bill payment and payroll direct deposit services. The company operates seven branches in Jim Thorpe, Albrightsville, Nesquehoning, Lehighton, Hometown, and West Penn. Mauch Chunk Trust Financial Corp. was founded in 1864 and is based in Jim Thorpe, Pennsylvania.
Full MCHT Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.